Literature DB >> 11304735

Power comparison of robust approximate and non-parametric tests for the analysis of cross-over trials.

J A Correa1, F Bellavance.   

Abstract

The main advantage of cross-over designs in practice is the use of a smaller number of subjects to produce treatment comparisons with sufficient precision. Bellavance and Tardif proposed a non-parametric approach to test the hypotheses of direct treatment and carry-over effects for the three-treatment three-period and six sequences cross-over design and showed the high asymptotic efficiency of their approach relative to the classical F-test based on ordinary least squares (OLS). In a more recent paper, Ohrvik suggested another non-parametric method for the analysis of cross-over trials. The power of these two non-parametric approaches is evaluated for small sample sizes via simulations, and compared to the power of the usual analysis of variance model based on OLS and a modified F-test approximation that take into account the correlation structure of the repeated measurements within subjects. Different covariance structures, sample sizes, and probability distributions for the responses, namely normal and gamma, are used in the simulations to evaluate the power and robustness of these different methods of analysis. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11304735     DOI: 10.1002/sim.776

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Transcription factor AP-2 beta genotype and psychosocial adversity in relation to adolescent depressive symptomatology.

Authors:  Kent W Nilsson; Rickard L Sjöberg; Jerzy Leppert; Lars Oreland; Mattias Damberg
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

2.  Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.

Authors:  Maartje C J Slagman; Femke Waanders; Marc H Hemmelder; Arend-Jan Woittiez; Wilbert M T Janssen; Hiddo J Lambers Heerspink; Gerjan Navis; Gozewijn D Laverman
Journal:  BMJ       Date:  2011-07-26

3.  A note on misspecification in general linear models with correlated errors for the analysis of crossover clinical trials.

Authors:  Wei Wang; Ning Cong; Tian Chen; Hui Zhang; Bo Zhang
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.